Get the Stockscreener App
58.68
0.02%
0.0232
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Bio Techne Corp stock is traded at $58.68, with a volume of 765.79K.
It is up +0.02% in the last 24 hours and up +15.38% over the past month.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
See More
Previous Close:
$58.66
Open:
$59.16
24h Volume:
765.79K
Relative Volume:
0.32
Market Cap:
$9.18B
Revenue:
$1.22B
Net Income/Loss:
$81.07M
P/E Ratio:
114.15
EPS:
0.5141
Net Cash Flow:
$223.02M
1W Performance:
+6.27%
1M Performance:
+15.38%
6M Performance:
-1.53%
1Y Performance:
+14.88%
1-Day Range:
$58.50
$59.78
1-Week Range:
$53.44
$60.44
52-Week Range:
$46.01
$72.16
Bio Techne Corp Stock (TECH) Company Profile
Name
Bio Techne Corp
Sector
Industry
Phone
612-379-8854
Address
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Compare TECH vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
58.67 | 9.18B | 1.22B | 81.07M | 223.02M | 0.5141 |
VRTX
Vertex Pharmaceuticals Inc
|
444.63 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
750.20 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
842.41 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
336.60 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.13 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-21-25 | Upgrade | Citigroup | Neutral → Buy |
| Jul-22-25 | Resumed | Stephens | Overweight |
| Jul-09-25 | Initiated | TD Cowen | Buy |
| May-30-25 | Initiated | Wells Fargo | Overweight |
| Apr-09-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Mar-18-25 | Initiated | Evercore ISI | Outperform |
| Feb-19-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-22-24 | Downgrade | Citigroup | Buy → Neutral |
| Feb-08-24 | Initiated | Scotiabank | Sector Outperform |
| Feb-02-24 | Downgrade | Stifel | Buy → Hold |
| Dec-07-23 | Initiated | UBS | Buy |
| Aug-28-23 | Initiated | William Blair | Outperform |
| Jan-10-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Sep-15-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-08-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Feb-23-21 | Upgrade | Stifel | Hold → Buy |
| Jan-25-21 | Reiterated | The Benchmark Company | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Jul-15-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| May-27-20 | Downgrade | Stifel | Buy → Hold |
| May-14-20 | Initiated | The Benchmark Company | Buy |
| Jan-08-20 | Resumed | Stephens | Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-02-19 | Upgrade | Janney | Neutral → Buy |
| Jan-14-19 | Upgrade | Stephens | Equal-Weight → Overweight |
| Oct-31-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-17-18 | Initiated | Goldman | Neutral |
| Jun-15-18 | Initiated | Argus | Buy |
| Jul-13-17 | Initiated | Wells Fargo | Market Perform |
| Feb-09-17 | Initiated | Citigroup | Buy |
| Jan-18-17 | Initiated | Deutsche Bank | Buy |
| Nov-10-16 | Resumed | Leerink Partners | Outperform |
| Jan-21-15 | Reiterated | Robert W. Baird | Outperform |
| Sep-20-13 | Upgrade | Robert W. Baird | Neutral → Outperform |
View All
Bio Techne Corp Stock (TECH) Latest News
Bio-Techne Corp. Experiences Revision in Stock Evaluation Amid Mixed Technical Indicators - Markets Mojo
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
Bio-Techne Corp (NASDAQ:TECH) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Sumitomo Mitsui Trust Group Boosts Stake in Bio-Techne - National Today
Massachusetts Financial Services Co. MA Has $235.99 Million Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Q1 2026 Bio-Techne Corp Earnings Call Transcript - GuruFocus
Traders Bet Big on Bio-Techne Decline with Put Options Surge - National Today
Traders Purchase High Volume of Put Options on Bio-Techne (NASDAQ:TECH) - MarketBeat
Rep. April McClain Delaney Sells Bio-Techne Corp Stock - National Today
Rep. April McClain Delaney Sells Bio-Techne Corp (NASDAQ:TECH) Stock - MarketBeat
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Bio-Techne Corp. Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
April McClain Delaney makes multiple trades in Bio-Techne, BJ’s Wholesale, and Nasdaq - Investing.com
Sivik Global Healthcare LLC Takes $2.65 Million Position in Bio-Techne Corp $TECH - MarketBeat
Precision Trading with Bio-techne Corp (TECH) Risk Zones - Stock Traders Daily
Bio-Techne (TECH) SVP exercises 2,259 RSUs, 740 shares withheld - Stock Titan
How Bio-Techne's Spatial Biology COMET Expansion (TECH) Has Changed Its Investment Story - simplywall.st
FOMO Trade: How much upside does Bio Techne Corporation haveWeekly Market Summary & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Bio-Techne (TECH) Stock Sees Analyst Price Target Downgrade | TECH Stock News - GuruFocus
Tudor Investment Corp Acquires $13.5M Stake in Bio-Techne - National Today
242,016 Shares in Bio-Techne Corp $TECH Acquired by Tudor Investment Corp ET AL - MarketBeat
TECH Should I Buy - Intellectia AI
Bio-Techne Corporation (TECH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bio-Techne earnings beat by $0.03, revenue topped estimates - Investing.com
Bio-Techne Corp (1TECH.MI) Analyst Insights, Price Targets & Recommendations - ca.finance.yahoo.com
Assessing Bio-Techne (TECH) Valuation After COMET Spatial Biology Platform Expansion - Yahoo Finance
TECH Stock Price, Quote & Chart | BIO-TECHNE CORP (NASDAQ:TECH) - ChartMill
SG Americas Securities LLC Acquires 126,702 Shares of Bio-Techne Corp $TECH - MarketBeat
ETF Watch: What are the future prospects of Bio Techne Corporation2026 Catalysts & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Small-MidCap Dividend Income Fund's Bio-Techne Corp(TECH) Holding History - GuruFocus
SPYRE Focus Panel launch fails to lift Bio-Techne stock amid pronounced bearish momentum - Traders Union
Fort Washington Investment Advisors Reduces Stake in Bio-Techne - National Today
Fort Washington Investment Advisors Inc. OH Sells 146,767 Shares of Bio-Techne Corp $TECH - MarketBeat
Technical Reactions to TECH Trends in Macro Strategies - Stock Traders Daily
Bio-Techne Corp. stock underperforms Friday when compared to competitors - MarketWatch
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know - Yahoo Finance
Riverbridge Partners LLC Has $46.21 Million Stake in Bio-Techne Corp $TECH - MarketBeat
Vanguard disaggregates holdings, reports 0% in Bio‑Techne (NASDAQ: TECH) - Stock Titan
Q4 Research Tools & Consumables Earnings: Bio-Techne (NASDAQ:TECH) Earns Top Marks - Yahoo Finance
Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite - The AI Journal
Bio-Techne expands spatial biology product portfolio - Investing.com
Bio-Techne expands spatial biology product portfolio By Investing.com - Investing.com UK
Bio-Techne adds tools aimed at harder-to-detect tissue targets - Stock Titan
Bio-Techne Sees Unusually Large Options Volume (NASDAQ:TECH) - MarketBeat
Bio-Techne Corp. stock rises Monday, still underperforms market - MarketWatch
Tudor Investment Corp ET AL Purchases Shares of 242,016 Bio-Techne Corp $TECH - MarketBeat
JPMorgan Chase Sells Stake in Bio-Techne Corp - National Today
JPMorgan Chase & Co. Sells 633,738 Shares of Bio-Techne Corp $TECH - MarketBeat
38,300 Shares in Bio-Techne Corp $TECH Purchased by Covea Finance - MarketBeat
After a Long Reset Period, Life Science Stocks Look Set to Rebound - Morningstar
How Is Bio-Techne's Stock Performance Compared to Other Biotechnology Stocks - Barchart.com
Bio Techne Corp Stock (TECH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Bio Techne Corp Stock (TECH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Herr Amy E. | Director |
Feb 17 '26 |
Sale |
59.10 |
1,976 |
116,791 |
200 |
2.64%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):